A system to rapidly develop a bunyavirus pseudotyped virus neutralisation assay for pandemic preparedness
Abstract Several Bunyavirales families have been listed as being of high pandemic or epidemic risk by the WHO R&D Blueprint. To support pandemic preparedness and the 100 Days Mission, along with rapid provision of vaccines and therapeutics, the development of tools to assess the immune response is r...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Nature Portfolio
2025-11-01
|
| Серія: | npj Vaccines |
| Онлайн доступ: | https://doi.org/10.1038/s41541-025-01278-8 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|